A survey of cystic fibrosis physicians' views on lung transplant referral in the era of elexacaftor/tezacaftor/ivacaftor

Burdis, N., Milinic, T., Bartlett, L. E., Goss, L., Tallarico, E., Boyle, A., Thaxton, A., Turner, G. A., Benvenuto, L. J., Faro, A., Goss, C. H., Kapnadak, S. G., & Ramos, K. J. (2024). A survey of cystic fibrosis physicians’ views on lung transplant referral in the era of elexacaftor/tezacaftor/ivacaftor. Pediatric Pulmonology, 59(12), 3641–3649. Portico. https://doi.org/10.1002/ppul.27273
Authors:
Nora Burdis
Tijana Milinic
Lauren E Bartlett
Louisa Goss
Erin Tallarico
Abigail Boyle
Abigail Thaxton
Grant A Turner
Luke J Benvenuto
Albert Faro
Christopher H Goss
Siddhartha G Kapnadak
Kathleen J Ramos
Affiliated Authors:
Luke J Benvenuto
Columbia Affiliation:
Subjects:
Cystic Fibrosis (MeSH)
Lung Transplantation (MeSH)
Benzodioxoles (MeSH)
Referral and Consultation (MeSH)
Drug Combinations (MeSH)
Pyridines (MeSH)
Pyrazoles (MeSH)
Indoles (MeSH)
Aminophenols (MeSH)
Quinolones (MeSH)
Author Keywords:
cystic fibrosis
elexacaftor/tezacaftor/ivacaftor
lung transplantation
physician survey
referral
elink
Publication Type:
Article
Unique ID:
10.1002/ppul.27273
PMID:
39291796
DOI:
10.1002/ppul.27273
Journal:
Pediatric Pulmonology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: